Is PSG.DE stock a buy on this intraday oversold bounce?

Intraday, PSG.DE stock shows a short-term bounce setup on volume. A controlled long with a tight stop (≈€28.40) and targets at €29.60 and €30.00 is reasonable. This is a tactical trade, not a long-term recommendation.

What is Meyka AI’s forecast for PSG.DE stock?

Meyka AI's forecast model projects €27.36 in one year, €29.48 in three years, and €31.56 in five years. These are model outputs and not guarantees; compare them with your own analysis.

Which valuation metrics should I watch for PSG.DE stock?

Key metrics: EPS €1.68, quoted PE €17.26, TTM PE €21.46 per Meyka, current ratio 2.68, and free cash flow yield ≈0.07. Watch inventory days (400.36) as an operational risk.

How liquid is PSG.DE stock for trading on XETRA?

Liquidity is thin relative to large caps: average volume **5,399.00** with intraday volume spiking to **12,424.00** today. Use limit orders and size positions to manage slippage and execution risk.

DE Stocks

€29.00 PSG.DE PharmaSGP SE (XETRA) intraday 10 Feb 2026: oversold bounce

ByDanny Kontos February 10, 2026February 10, 2026

PSG.DE stock trades at €29.00 intraday on XETRA on 10 Feb 2026 as volume ticks higher, setting up an oversold bounce opportunity. The stock opened at €28.80, hit a day low of €28.60, and has a relative volume of 2.30, suggesting active short-term interest. We examine technical triggers, valuation, and a trading plan for an intraday bounce in Germany’s healthcare segment.